Human Immunodeficiency Virus (HIV) and Hepatitis Virus Coinfection among HIV-Infected Korean Patients: The Korea HIV/AIDS Cohort Study
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Yong Chan | - |
dc.contributor.author | Ahn, Jin Young | - |
dc.contributor.author | Kim, June Myung | - |
dc.contributor.author | Kim, Youn Jeong | - |
dc.contributor.author | Park, Dae Won | - |
dc.contributor.author | Yoon, Young Kyung | - |
dc.contributor.author | Song, Joon Young | - |
dc.contributor.author | Kim, Shin Woo | - |
dc.contributor.author | Lee, Jin Soo | - |
dc.contributor.author | Choi, Bo Youl | - |
dc.contributor.author | Choi, Yun Su | - |
dc.contributor.author | Choi, Ju-yeon | - |
dc.contributor.author | Han, Myung Guk | - |
dc.contributor.author | Kang, Chun | - |
dc.contributor.author | Choi, Jun Yong | - |
dc.date.accessioned | 2021-09-02T22:45:16Z | - |
dc.date.available | 2021-09-02T22:45:16Z | - |
dc.date.created | 2021-06-16 | - |
dc.date.issued | 2017-12 | - |
dc.identifier.issn | 2093-2340 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/81426 | - |
dc.description.abstract | Background: Despite declines in mortality and morbidity rates of patients with human immunodeficiency virus (HIV) infection as the result of highly active antiretroviral therapy, liver diseases due to chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are a leading cause of death among HIV-infected patients. However, HIV and HBV or HCV coinfection is still poorly documented, and more information is needed to better understand the characteristics of HIV-infected patients in Korea. Materials and Methods: A cross-sectional study was performed to investigate clinical characteristics and prevalence of HBV and HCV infection in HIV patients enrolled in the Korea HIV/acquired immune deficiency syndrome (AIDS) cohort study from 17 institutions between December 2006 and July 2013. Results: Among the 1,218 HIV-infected participants, 541 were included in this study. The prevalence of HBV-HIV and HCV-HIV coinfection was 5.0% (27/541) and 1.7% (9/541), respectively. There was no patient who was positive for both HBs antigen and HCV antibody. In multivariate logistic regression analysis, HBV unvaccinated status was a significant risk factor for HBV-HIV coinfection (odds ratio = 4.95, 95% confidence interval = 1.43-17.13). Conclusion: HBV and HCV infection was more common in HIV-infected persons enrolled in the Korean HIV/AIDS cohort, than in the general population in Korea. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | KOREAN SOC CHEMOTHERAPY | - |
dc.subject | DEFINING OPPORTUNISTIC ILLNESSES | - |
dc.subject | SUB-SAHARAN AFRICA | - |
dc.subject | VIRAL-HEPATITIS | - |
dc.subject | C VIRUS | - |
dc.subject | SOUTH-KOREA | - |
dc.subject | B-VIRUS | - |
dc.subject | METAANALYSIS | - |
dc.subject | MORTALITY | - |
dc.subject | AIDS | - |
dc.subject | PROGRESSION | - |
dc.title | Human Immunodeficiency Virus (HIV) and Hepatitis Virus Coinfection among HIV-Infected Korean Patients: The Korea HIV/AIDS Cohort Study | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Park, Dae Won | - |
dc.contributor.affiliatedAuthor | Yoon, Young Kyung | - |
dc.contributor.affiliatedAuthor | Song, Joon Young | - |
dc.identifier.doi | 10.3947/ic.2017.49.4.268 | - |
dc.identifier.scopusid | 2-s2.0-85040022841 | - |
dc.identifier.wosid | 000419578400004 | - |
dc.identifier.bibliographicCitation | INFECTION AND CHEMOTHERAPY, v.49, no.4, pp.268 - 274 | - |
dc.relation.isPartOf | INFECTION AND CHEMOTHERAPY | - |
dc.citation.title | INFECTION AND CHEMOTHERAPY | - |
dc.citation.volume | 49 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 268 | - |
dc.citation.endPage | 274 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002304789 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Infectious Diseases | - |
dc.relation.journalWebOfScienceCategory | Infectious Diseases | - |
dc.subject.keywordPlus | DEFINING OPPORTUNISTIC ILLNESSES | - |
dc.subject.keywordPlus | SUB-SAHARAN AFRICA | - |
dc.subject.keywordPlus | VIRAL-HEPATITIS | - |
dc.subject.keywordPlus | C VIRUS | - |
dc.subject.keywordPlus | SOUTH-KOREA | - |
dc.subject.keywordPlus | B-VIRUS | - |
dc.subject.keywordPlus | METAANALYSIS | - |
dc.subject.keywordPlus | MORTALITY | - |
dc.subject.keywordPlus | AIDS | - |
dc.subject.keywordPlus | PROGRESSION | - |
dc.subject.keywordAuthor | HIV infection | - |
dc.subject.keywordAuthor | Hepatitis B virus | - |
dc.subject.keywordAuthor | Hepatitis C virus | - |
dc.subject.keywordAuthor | Coinfection | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.